Frontdoor Reports Strong 2025 Financials with Double-Digit Growth and Substantial Share Repurchase

summarizeSummary

Frontdoor, Inc. reported strong full-year 2025 financial results, including 14% revenue growth and 25% Adjusted EBITDA growth, alongside a significant $280 million share repurchase program.

check_boxKey Events

• Record Full-Year 2025 Financials

  Revenue increased 14% to $2.093 billion, and Adjusted EBITDA grew 25% to $553 million. Net income rose 8.5% to $255 million, with diluted EPS at $3.42.

• Substantial Share Repurchase Program

  The company repurchased $280 million of common stock in 2025, with $329 million remaining available under the $650 million authorization approved in July 2024.

• CEO's 10b5-1 Plan Terminated

  CEO William C. Cobb terminated a Rule 10b5-1 trading plan on November 6, 2025, which had been adopted on August 7, 2025, for up to 191,036 shares. No sales were made under the plan prior to its termination.

• Unqualified Audit Opinion

  Deloitte & Touche LLP issued an unqualified opinion on the financial statements and the effectiveness of internal control over financial reporting for 2025.

auto_awesomeAnalysis

Frontdoor, Inc. has filed its comprehensive annual report, confirming robust financial performance for 2025. The company achieved significant revenue and Adjusted EBITDA growth, demonstrating strong operational execution. This filing follows an 8-K on the same day that initially reported these record results, with the 10-K providing full audited details and extensive context. A notable capital allocation move was the repurchase of $280 million in common stock during 2025, with a substantial amount remaining under the current authorization. While the number of home warranties and customer retention rate saw a slight decline, attributed to challenging real estate market conditions, the overall financial picture remains positive. The company also received an unqualified audit opinion on its financial statements and internal controls. Investors should note the termination of the CEO's 10b5-1 trading plan, though no sales occurred under it.